Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome
HemaSphere · 2026-11 · 10 (11)
DOI: 10.1002/hem3.70512 ↗Kurz gefasst
Leserbrief in der Zeitschrift HemaSphere, online erschienen am 10.11.2026. Verfasst von Bhavisha A Patel und 34 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health Bethesda Maryland United States. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health Bethesda Maryland United States.
- Immune Deficiency Cellular Therapy Program National Cancer Institute, National Institutes of Health Bethesda Maryland United States.
- Vasculitis Translational Research Program National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health Bethesda Maryland United States.
- Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda Maryland United States.
- Translational Stem Cell Biology Branch National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda Maryland United States.
- Division of Rheumatology, Allergy, and Clinical Immunology University of Maryland Medical Center Baltimore Maryland United States.
ORCID-Profile: Bhavisha A Patel, Xingmin Feng, Fernanda Gutierrez-Rodrigues, Benjamin Turturice, Corina Gonzalez, Chuanfeng Wu, Jennifer Cuellar-Rodriguez, Mary Czech, David B Beck, Neal S Young, Sung-Yun Pai, Peter C Grayson, Emma M Groarke
Förderung
- National Cancer Institute
- National Heart, Lung, and Blood Institute
Zitieren
APA
Patel, B. A., Dias, A., Avila, D., Jenkins, T., Duncan, L., Merkel, R., Fike, A., Onyechi, J., Feng, X., Gutierrez-Rodrigues, F., Darden, I., Liu, S., Turturice, B., Hendricks, J., Flannelly, E., Cole, K., Parmar, K., Shalhoub, R., Wu, C. O., …, & Groarke, E. M. (2026). Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome. HemaSphere, 10(11). https://doi.org/10.1002/hem3.70512
Vancouver
Patel BA, Dias A, Avila D, Jenkins T, Duncan L, Merkel R, et al. Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome. HemaSphere. 2026;10(11). doi:10.1002/hem3.70512
BibTeX
@article{Patel2026,
author = {Patel, Bhavisha A and Dias, Ajoy and Avila, Daniele and Jenkins, Tonya and Duncan, Lisa and Merkel, Roxanne and Fike, Alice and Onyechi, Julie and Feng, Xingmin and Gutierrez-Rodrigues, Fernanda and Darden, Ivana and Liu, Shanni and Turturice, Benjamin and Hendricks, Jennifer and Flannelly, Erin and Cole, Kristen and Parmar, Kanak and Shalhoub, Ruba and Wu, Colin O and Lotter, Jennifer and Kang, Boeui and Kajigaya, Sachiko and Gonzalez, Corina and Wu, Chuanfeng and Ferrada, Marcela A and Cuellar-Rodriguez, Jennifer and Czech, Mary and Calvo, Katherine R and Childs, Richard W and Beck, David B and Young, Neal S and Pai, Sung-Yun and Hickstein, Dennis D and Grayson, Peter C and Groarke, Emma M},
title = {Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {11},
doi = {10.1002/hem3.70512}
}
EUVIMED